Ads
related to: mustard atrial switch procedure instructions free- Aortic Stenosis
Aortic stenosis is progressive.
Don't wait to act.
- What Is TAVR?
A less invasive option for severe
aortic stenosis with symptoms.
- Watch Patient Videos
Meet patients who treated
their severe aortic stenosis.
- Treatment Options
Learn about your treatment options
for SAS with symptoms.
- Heart Valve Failure
Learn about heart valve failure
and why to treat it.
- TAVR Valves
Your valve choice matters.
Read about TAVR valve options.
- Aortic Stenosis
Search results
Results From The WOW.Com Content Network
The Mustard procedure was developed in 1963 by Dr. William Mustard at the Hospital for Sick Children.It is similar to the previous atrial baffle used with a Senning procedure, the primary difference being that the Mustard uses a graft made of Dacron or pericardium, while the Senning uses native heart tissue.
Arterial switch operation (ASO) or arterial switch, is an open heart surgical procedure used to correct dextro-transposition of the great arteries (d-TGA). [1] [2]Its development was pioneered by Canadian cardiac surgeon William Mustard and it was named for Brazilian cardiac surgeon Adib Jatene, who was the first to use it successfully.
Atrial switch is a heart operation performed to treat dextro-Transposition of the great arteries. [ 1 ] [ 2 ] It involves the construction of an atrial baffle which redirects the blood coming into the atria to restore the connection between systemic and pulmonary circulation.
In the case of sepsis or late diagnosis, a delayed Arterial Switch can sometimes be made possible by PAB, which may also require a concomitant construction of an aortic-to-pulmonary artery shunt. [2] When an arterial switch is impossible, an atrial switch will be attempted using either the Senning or Mustard procedure. [7]
The Senning procedure is an atrial switch heart operation performed to treat transposition of the great arteries. It is named after its inventor, the Swedish cardiac surgeon Åke Senning (1915–2000), also known for implanting the first permanent cardiac pacemaker in 1958.
The system, PulseSelect Pulsed Field Ablation (PFA), is used for the treatment of atrial fibrillation (AF), a condition that is characterized by an irregular rhythm of the heart.